Jack Goldstein

Jack Goldstein

Plus aucun poste en cours
79 ans
Health Technology
Consumer Services
Finance

Profil

Jack Goldstein formerly worked at Applied Imaging Corp., as Chairman from 2001 to 2002, OncoGenex Pharmaceuticals, Inc., as Chairman from 2010 to 2017, Immucor, Inc., as Director from 2006 to 2009, Illumina, Inc., as Director from 2006 to 2010, OraSure Technologies, Inc., as Director from 2006 to 2011, Myriad Women's Health, Inc., as Director from 2016 to 2017, Accuray, Inc., as Independent Director from 2010 to 2020, Baxter Healthcare Corp., as Vice President-Research & Development, Chiron Corp., as President & Chief Operating Officer from 2004 to 2006, Johnson & Johnson, as President-Ortho Diagnostic Systems from 1986 to 1997, Windamere Venture Partners LLC, as General Partner from 2000 to 2002, Ortho Diagnostic Systems, Inc., as President, and Professional Diagnostics, Inc., as Executive Vice President from 1986 to 1997.
Dr. Goldstein received his undergraduate degree from Rider University and graduate degree and doctorate degree from St. John's University.

Anciens postes connus de Jack Goldstein

SociétésPosteFin
ACCURAY INCORPORATED Directeur/Membre du Conseil 20/11/2020
Président 01/08/2017
Directeur/Membre du Conseil 01/05/2017
ORASURE TECHNOLOGIES, INC. Directeur/Membre du Conseil 07/04/2011
ILLUMINA, INC. Directeur/Membre du Conseil 12/05/2010
Voir l'expérience en détail de Jack Goldstein

Formation de Jack Goldstein

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

73

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Ortho Diagnostic Systems, Inc.

Finance

  1. Bourse
  2. Insiders
  3. Jack Goldstein
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT